Annals of Emergency Medicine
Volume 45, Issue 6 , Pages 573-580 , June 2005

Predictors of Elevated B-Type Natriuretic Peptide Concentrations in Dyspneic Patients Without Heart Failure: An Analysis From the Breathing Not Properly Multinational Study

Received 25 August 2004 ,Revised 30 November 2004 ,Accepted 17 January 2005.

References 

  1. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195–203
  2. Ogawa Y, Nakao K, Mukoyama M, et al. Rat brain natriuretic peptide: tissue distribution and molecular form. Endocrinology. 1990;126:2225–2227
  3. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest. 1991;87:1402–1412
  4. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart. Hypertension. 1991;17:1152–1156
  5. Ogawa Y, Nakao K, Mukoyama M, et al. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats: the ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res. 1991;69:491–500
  6. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation. 1995;92:1558–1564
  7. Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med. 1990;323:757–758
  8. Richards AM. The natriuretic peptides in heart failure. Basic Res Cardiol. 2004;99:94–100
  9. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. 2003;41:571–579
  10. McCullough PA, Joseph K, Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med. 2004;5:16–25
  11. Maisel A, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
  12. McCollough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgement in the emergency diagnosis of heart failure. Circulation. 2002;106:416–422
  13. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002;39:131–138
  14. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202–209
  15. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562
  16. Schocken DD, Arrieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–306
  17. Nagagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an “emergency” cardiac hormone against ventricular overload. J Clin Invest. 1995;96:1280–1287
  18. Maeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825–832
  19. Raymond I, Groenning BA, Hildebrandt PR, et al. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart. 2003;89:745–751
  20. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–982
  21. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002;90:254–258
  22. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43:1590–1595
  23. Wang TJ. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600
  24. McCord J, Mundy BJ, Hudson MP, et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med. 2004;164:2247–2252
  25. Yamamoto K, Burnett JC, Jougasaki M, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988–994
  26. Foy SG, Crozier IG, Richards AM, et al. Neurohormonal changes after acute myocardial infarction: relationships with haemodynamic indices and effects of ACE inhibition. Eur Heart J. 1995;16:770–778
  27. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 1993;88:82–91
  28. Omland T, Aakvaag A, Bonarjee VVS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation. 1996;93:1963–1969
  29. Mukoyama M, Nakao K, Obata K, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun. 1991;180:431–436
  30. Talwar S, Squire IB, Downie PF, et al. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart. 2000;84:421–424
  31. Kruger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J. 2004;147:60–65
  32. Ishii J, Nomura M, Ito M, et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta. 2000;301:19–30
  33. Silvet H, Young-Xu Y, Walleigh D. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol. 2003;92:1124–1127
  34. Rossi A, Enriquez-Sarano M, Burnett JC, et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol. 2000;35:1256–1262
  35. Badgett RG, Mulrow CD, Otto PM, et al. How well can chest radiograph diagnose left ventricular dysfunction?. J Gen Intern Med. 1996;11:625–634
  36. Clark AL, Coats AJ. Unreliability of cardiothoracic ratio as a marker of left ventricular impairment: comparison with radionuclide ventriculography and echocardiography. Postgrad Med J. 2000;76:289–291
  37. Kalra PR, Anagnostopoulos C, Bolger AP, et al. The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol. 2002;39:1901–1908
  38. Feigenbaum MS, Welsch MA, Mitchell M, et al. Contracted plasma and blood volume in chronic heart failure. J Am Coll Cardiol. 2000;35:51–55
  39. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol. 2004;43:416–422
  40. Omland T. N-terminal pro-BNP: marker of systolic dysfunction or nonspecific indicator of cardiac disease [editorial]?. Heart Drug. 2003;3:122–124
  41. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655–663

 Author contributions: CWK, PC, AHBW, PD, JM, RMN, JEH, ABS, WTA, PMC, AM, and TO conceived and designed the study. JEH and ABS obtained funding, and AHBW, RMN, and WTA provided administrative/technical support. CWK, AHBW, PD, RMN, JEH, ABS, WTA, PMC, and AM participated in data acquisition. CWK, PC, AW, TOK, RMN, JEH, AM, and TO participated in data analysis and interpretation of data. CWK and TO drafted the manuscript. CWK, PC, and TO provided statistical expertise. PC, AW, TOK, AHBW, JM, RMN, JEH, ABS, WTA, PMC, AM, and TO critically revised the manuscript. TO and CWK take responsibility for the paper as a whole.Funding and support: Triage BNP devices and meters and some financial support were provided by Biosite, Inc., San Diego, CA. The following authors have received honoraria from the manufacturer of the BNP assay used in the study: Maisel, Clopton, Nowak, McCord, Hollander, Duc, Omland, Abraham, Wu, and McCullough.

PII: S0196-0644(05)00134-4

doi: 10.1016/j.annemergmed.2005.01.027

Annals of Emergency Medicine
Volume 45, Issue 6 , Pages 573-580 , June 2005

Article Tools

* Image Usage & Resolution